Skip to main content

Table 2 Definition of diabetic patients with declining renal function

From: Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France

Diabetic patients

 

25,458

 
 

2 Measurements of creatinine clearance and 2 Measurements of urinary protein within a one-year time frame

2,109

8,3%

OR

At least one record associated with a long term condition “chronic nephropathy and primitive nephrotic syndrom” and at least one ICD 10 code related to chronic kidney failure

127

0,5%

OR

At least one prescription dispensing of treatment from the following list associated to a nephrologist visit: ACE-I (Angiotensin converting enzyme inhibitors) and A2RA (Angiotensin II receptor antagonists) in association, phosphorus chelators (*), polystyrene sulfonate (**), Angiotensin converting enzyme (ACE) inhibitors,

496

1,9%

OR

At least two dispensings with an interval from 30 to 365 days of a conbination of following treatment: ACE-I, A2RA, phosphorus chelators (*), polystyrene sulfonate (**)

170

0,7%

Total number of patients with a chronic kidney failure (CKF) (Declining Renal Function)

2,535

10,0%

Patients with terminal CKF: patients with a CKF and…:

 

At least 2 records associated with a CCAM code related to dialyse within a One-week time period

67

0,3%

OR

At least 2 prescription dispensings of erythropoietin AND 2 prescriptions dispensing of phosphorus chelators within a 45 days-time period

22

0,1%

Total number of patients with a terminal CKF

80

0,3%

Patients with severe CKF: patients with a CKF…

585

2,3%

 

At least 2 prescription dispensings of erythropoietin

470

1,8%

OR

At least 2 prescription dispensings of phosphorus chelators

140

0,5%

OR

At least 4 nephrologist visits within 12-months time frame

58

0,2%

Total number of patients with a severe CKF

585

2,3%

Patients with moderate CKF: Patients with a CKF not defined as severe or terminal

 

Total number of patients with moderate CKF

1,870

7,3%